Stanford's Katrin Svensson and Utah's Flynn McGuire push back on 'natural means safe' talk about BPC-157, as an FDA panel with industry ties votes to loosen access.
Recap by typeshit. Full story at The Palm Beach Post.
MedPage Today
A JAMA Network Open analysis of Reddit posts also lists fatigue, insomnia and muscle symptoms. MedPage's roundup adds a CagriSema menopause analysis and Walmart's GLP-1 coverage plan.
A short teaser comparing how well people tolerate the two main GLP-1 ingredients, with the full breakdown behind the link.
Doctors quoted by Men's Journal raise concerns about how much GLP-1 users are paying for add-on supplements each month.
The anti-doping agency says many sellers use research chemical labels to dodge FDA scrutiny while selling peptides and SARMs.
Dr. Regina DePietro of MU Health Care says unapproved injectables sold "for research" lack safety checks, and the products could be fake or useless.
One semaglutide trial saw about two thirds of lost weight return within a year. Pearson points to protein, strength training, sleep and weekly weigh-ins.
Loading…